Clinical Trial

Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram.

Study acronym: VRL-CT-26-006
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy of adjunctive CreNeuroSTM CNS Fish Oil Plus Softgels in patients with Major Depressive Disorder receiving escitalopram.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-09.
Trial Details
NCT Number NCT07645807
Lead Sponsor Sichuan Credit Pharmaceutical Co., Ltd.
Collaborators: Vivotech Research Lab Pvt Ltd
Conditions Adjunct in the Treatment of Depressive Disorder
Enrollment 80 participants
Start Date 2026-06-11
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-16